Page last updated: 2024-10-29

ifosfamide and Granulomatosis, Wegener's

ifosfamide has been researched along with Granulomatosis, Wegener's in 1 studies

Research Excerpts

ExcerptRelevanceReference
" Three groups of patients were prospectively evaluated: Group I: 15 patients with Wegener's granulomatosis and 4 patients with severe scleritis received a single dose cyclophosphamide (15 mg/kg bw/day) and 250 mg prednisone i."3.70Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide). ( Jockenhövel, F; Kummer, G; Mann, K; Philipp, T; Reinhardt, W; Reinwein, D; Sauter, V; Uppenkamp, M; Witzke, O, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reinhardt, W1
Sauter, V1
Jockenhövel, F1
Kummer, G1
Uppenkamp, M1
Witzke, O1
Philipp, T1
Reinwein, D1
Mann, K1

Other Studies

1 other study available for ifosfamide and Granulomatosis, Wegener's

ArticleYear
Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide).
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1999, Volume: 107, Issue:3

    Topics: Adult; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexameth

1999